Asset Dedication’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.8K Hold
18
– – ﹤0.01% 797
2026
Q2
$9.8K Buy
+18
New +$10.1K ﹤0.01% 791

Other funds holding UTHR

Asset Dedication's UTHR Position: Q3 2026 in Review

Asset Dedication held its United Therapeutics (UTHR) position steady in Q3 2026 at 18 shares worth $9.8K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Asset Dedication first reported a position in UTHR in Q2 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Asset Dedication held 18 shares of United Therapeutics worth $9.8K as of Q3 2026.
  • Asset Dedication left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #797 holding.
  • Asset Dedication first reported a position in United Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.